Efruxifermin: one step closer to disease-modifying therapy in fibrotic MASH

Jonathan G. Stine

doi:10.1016/S0140-6736(25)01147-X

Efruxifermin: one step closer to disease-modifying therapy in fibrotic MASH

Jonathan G. Stine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	666-667
Number of pages	2
Journal	The Lancet
Volume	406
Issue number	10504
DOIs	https://doi.org/10.1016/S0140-6736(25)01147-X
State	Published - Aug 16 2025

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1016/S0140-6736(25)01147-X

Cite this

@article{aa42d704d45e4beda96076b2ff98ea2b,

title = "Efruxifermin: one step closer to disease-modifying therapy in fibrotic MASH",

author = "Stine, \{Jonathan G.\}",

year = "2025",

month = aug,

day = "16",

doi = "10.1016/S0140-6736(25)01147-X",

language = "English (US)",

volume = "406",

pages = "666--667",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10504",

}

TY - JOUR

T1 - Efruxifermin

T2 - one step closer to disease-modifying therapy in fibrotic MASH

AU - Stine, Jonathan G.

PY - 2025/8/16

Y1 - 2025/8/16

UR - https://www.scopus.com/pages/publications/105013093824

UR - https://www.scopus.com/pages/publications/105013093824#tab=citedBy

U2 - 10.1016/S0140-6736(25)01147-X

DO - 10.1016/S0140-6736(25)01147-X

M3 - Comment/debate

C2 - 40818843

AN - SCOPUS:105013093824

SN - 0140-6736

VL - 406

SP - 666

EP - 667

JO - The Lancet

JF - The Lancet

IS - 10504

ER -

Efruxifermin: one step closer to disease-modifying therapy in fibrotic MASH

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this